Publications by authors named "Jennifer Streit"

Claim this Profile
C
Contemporary Evaluation of Tebipenem Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019-2020).
Rodrigo E Mendes, S J Ryan Arends, Jennifer M Streit, Ian Critchley, Nicole Cotroneo

Microbiol Spectr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of Ceftolozane-Tazobactam Against Gram-Negative Isolates from Australia and New Zealand as part of the PACTS Surveillance 2016-2018.
Dee Shortridge, Jennifer Streit, Michael Pfaller, Merrin Tulloch, Wei-Ting Chen

J Glob Antimicrob Resist· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA, Europe, Latin America, and the Asia-Pacific region (2015-2019).
Michael Pfaller, Rodrigo E Mendes, Jennifer M Streit, Cecilia G Carvalhaes

Diagn Microbiol Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year analysis of the activity of tedizolid against a worldwide collection of indicated species causing clinical infections: results from the Surveillance of Tedizolid Activity and Resistance (STAR) programme.
Cecilia G Carvalhaes, Helio S Sader, Jennifer M Streit, Rodrigo E Mendes

JAC Antimicrob Resist· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of meropenem/vaborbactam and comparators against non-carbapenemase-producing carbapenem-resistant Enterobacterales isolates from Europe.
Dee Shortridge, Lalitagauri M Deshpande, Jennifer M Streit, Mariana Castanheira

JAC Antimicrob Resist· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Activity of Cefiderocol against U.S. and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance Program.
Dee Shortridge, Jennifer M Streit, Rodrigo Mendes, Mariana Castanheira

Microbiol Spectr· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019).
Cecilia G Carvalhaes, Helio S Sader, Jennifer M Streit, Mariana Castanheira, Rodrigo E Mendes

Antimicrob Agents Chemother· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of the Novel Aminomethylcycline KBP-7072 and Comparators against 1,057 Geographically Diverse Recent Clinical Isolates from the SENTRY Surveillance Program, 2019.
Michael D Huband, Jennifer D Thompson, Nabina D Gurung, Qingmei Liu, Li Li, Jennifer M Streit

Antimicrob Agents Chemother· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020).
Helio S Sader, Rodrigo E Mendes, Jennifer M Streit, Cecilia G Carvalhaes, Mariana Castanheira

Diagn Microbiol Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019.
Rodrigo E Mendes, Timothy B Doyle, Jennifer M Streit, Francis F Arhin, Helio S Sader

J Antimicrob Chemother· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minocycline Activity against Unusual Clinically Significant Gram-Negative Pathogens.
Dee Shortridge, S J Ryan Arends, Jennifer M Streit, Mariana Castanheira

Antimicrob Agents Chemother· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016-19).
Helio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, Michael D Huband, Dee Shortridge

JAC Antimicrob Resist· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012-2018).
Dee Shortridge, Cecilia G Carvalhaes, Jennifer M Streit, Robert K Flamm

Diagn Microbiol Infect Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Comparators Tested Against and Isolates from United States Medical Centers in 2016-2018.
Helio S Sader, Cecilia G Carvalhaes, Jennifer M Streit, Timothy B Doyle, Mariana Castanheira

Microb Drug Resist· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial activity of dalbavancin against clinical isolates of coagulase-negative staphylococci from the USA and Europe stratified by species.
Helio S Sader, Cecilia G Carvalhaes, Jennifer M Streit, S J Ryan Arends, Rodrigo E Mendes

J Glob Antimicrob Resist· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the in vitro activity of dalbavancin against indicated species (Staphylococcus aureus, Enterococcus faecalis, β-hemolytic streptococci, and Streptococcus anginosus group) collected from United States hospitals in 2017-2019.
Helio S Sader, Jennifer M Streit, Rodrigo E Mendes

Diagn Microbiol Infect Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014-2019).
Dee Shortridge, Michael A Pfaller, Jennifer M Streit, Robert K Flamm

J Glob Antimicrob Resist· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and antimicrobial susceptibility of bacteria causing bloodstream infections in pediatric patients from United States (US) medical centers (2014-2018): therapeutic options for multidrug-resistant bacteria.
Helio S Sader, Mariana Castanheira, Jennifer M Streit, Cecilia G Carvalhaes, Rodrigo E Mendes

Diagn Microbiol Infect Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of ceftolozane-tazobactam and comparators when tested against bacterial surveillance isolates collected from patients at risk of infections caused by resistant gram-negative pathogens.
Michael A Pfaller, Dee Shortridge, S J Ryan Arends, Leonard R Duncan, Jennifer M Streit

Diagn Microbiol Infect Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms.
Rodrigo E Mendes, Michael D Huband, Jennifer M Streit, Mariana Castanheira, Robert K Flamm

Diagn Microbiol Infect Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme.
Dee Shortridge, Michael A Pfaller, Jennifer M Streit, Robert K Flamm

J Glob Antimicrob Resist· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Tedizolid Activity and Resistance Mechanisms against a Collection of spp. Causing Invasive Infections, Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from U.S. and European Medical Centers, 2016 to 2018.
Cecilia G Carvalhaes, Helio S Sader, Robert K Flamm, Jennifer M Streit, Rodrigo E Mendes

Antimicrob Agents Chemother· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America.
Helio S Sader, Cecilia G Carvalhaes, Jennifer M Streit, Mariana Castanheira, Robert K Flamm

Int J Infect Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bloodstream infections in United States medical centers (2015-2017).
Helio S Sader, Mariana Castanheira, Jennifer M Streit, Robert K Flamm

Diagn Microbiol Infect Dis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic and Temporal Patterns of Antimicrobial Resistance in Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016.
Dee Shortridge, Ana C Gales, Jennifer M Streit, Michael D Huband, Athanasios Tsakris

Open Forum Infect Dis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis